Trial Profile
Safety and Efficacy Study Comparing a New hMG Formulation (hMG-IBSA) to a Reference Product (Menopur[Rm]) in Patients Undergoing Ovarian Stimulation for in Vitro Fertilisation (IVF).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Sponsors IBSA
- 28 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Mar 2012 Planned End Date changed from 1 Dec 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 15 Dec 2011 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.